How do semaglutide and tirzepatide actually work?
Both medications belong to a family of drugs that mimic gut hormones your body naturally releases after eating. These hormones help signal fullness to the brain, slow how quickly your stomach empties, and support steadier blood sugar. The result, for many people, is a reduced appetite and smaller portions without the constant feeling of willpower struggle.
The key difference is how many hormone pathways each one engages. Semaglutide acts on a single receptor (GLP-1). Tirzepatide acts on two receptors (GLP-1 and GIP), which is why it is sometimes called a dual-action medication. Engaging a second pathway appears to add to the appetite and metabolic effects for many patients.
Semaglutide (single-action)
- Targets one receptor: GLP-1
- Mimics one gut hormone
- Reduces appetite, slows stomach emptying
- Weekly injection under the skin
Tirzepatide (dual-action)
- Targets two receptors: GLP-1 and GIP
- Mimics two gut hormones
- Often a stronger appetite effect on average
- Weekly injection under the skin
What kind of results can each one produce?
In clinical studies, both medications helped many participants lose a meaningful percentage of their body weight when combined with reduced-calorie eating and increased activity. On average, tirzepatide produced somewhat greater weight loss than semaglutide in head-to-head and comparative research. That said, averages are not promises, and individual results vary widely.
Results also depend on dose, how long you stay on treatment, lifestyle changes, and your individual biology. Both medications are typically started at a low dose and increased gradually over weeks to help your body adjust and limit side effects. Meaningful change usually unfolds over months, not days.
- 1
Weeks 1-4
Lowest starting dose; body adjusts; mild side effects most common
- 2
Weeks 5-16
Gradual dose increases as tolerated; appetite changes become noticeable
- 3
Months 4-6
Approaching a maintenance dose; steadier progress for many
- 4
Ongoing
Continued supervision; plan reviewed regularly with your clinician
How do the side effects compare?
The two medications share a similar side-effect profile because they work through related pathways. The most common effects are digestive: nausea, vomiting, diarrhea, constipation, and reduced appetite. These tend to be most noticeable early or just after a dose increase, and often ease as your body adjusts. Starting low and going slow is designed to soften this.
- Common: nausea, constipation, diarrhea, burping, fatigue, injection-site reactions
- Less common but important: gallbladder problems, dehydration from vomiting or diarrhea, low blood sugar (especially if combined with certain other medications)
- Rare but serious: pancreatitis (severe, persistent abdominal pain) — seek care promptly
These medications are not appropriate for everyone. They carry a boxed warning related to a type of thyroid tumor seen in animal studies, and they are generally avoided in people with a personal or family history of medullary thyroid carcinoma or a condition called MEN 2. They are also not used during pregnancy or while trying to conceive. A thorough medical history is essential before starting.
What do they cost, and how are they compared side by side?
Cost varies a great deal depending on the specific product, your dose, your location, and whether any insurance coverage applies. Many people pay out of pocket for weight-management use. The figures below are broad, illustrative ranges to help you plan a conversation, not quotes.
| Factor | Semaglutide | Tirzepatide |
|---|---|---|
| Hormone pathways | One (GLP-1) | Two (GLP-1 + GIP) |
| How it's given | Weekly injection | Weekly injection |
| Average weight loss in studies | Meaningful for many | Somewhat greater on average |
| Common side effects | Mostly digestive | Mostly digestive |
| Typical monthly cost (out of pocket) | Often several hundred to ~$1,000+ | Often several hundred to ~$1,000+ |
Because pricing shifts and savings programs come and go, treat cost as something to verify in real time. Ask any clinic about the medication's source, what's included in a monthly fee, what monitoring visits cost, and whether prices change as your dose increases.
Who is a good candidate, and how do you choose?
These medications are generally considered for adults whose weight meets certain medical thresholds, often alongside weight-related health conditions, and who have not reached their goals with lifestyle changes alone. The decision is individualized. A clinician weighs your medical history, current medications, and goals before recommending one option over the other.
- Your full medical and family history, including thyroid and pancreatic concerns
- How well you tolerate digestive side effects
- Other medications you take, to avoid interactions
- Cost and what you can sustain over the long term
- Your goals and how the medication fits a broader plan
- 01
Step 1
Consultation and full medical history review
- 02
Step 2
Discuss goals, risks, costs, and alternatives
- 03
Step 3
Start at the lowest dose with clear instructions
- 04
Step 4
Check in regularly; adjust dose as tolerated
- 05
Step 5
Review progress and long-term plan together
There is no single "better" choice for everyone. Tirzepatide's dual action may offer more for some, while semaglutide has a longer track record in certain settings and may be the right fit for others. The most important factor is working with a clinician who supervises your care from start to finish.